The Prime Minister just announced the current development regarding COVID-19 vaccine suppliers for Malaysia. Malaysia has signed an agreement with COVAX, Pfizer and Astra Zeneca and will finalize three more agreements with Sinovac, Cansino and Gamaleya.
So far, all of these agreements will give Malaysia COVID-19 vaccine access to 83 % national population or 26.5 million people with a cost of RM2. 05 billion.